We are live on ! Find out more
PASG icon

Passage Bio
PASG

70 hedge funds and large institutions have $403M invested in Passage Bio in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 12

6% more funds holding

Funds holding: 66 → 70 (+4)

0.1% less ownership

Funds ownership: 3.48% → 3.38% (-0.1%)

20% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 20

50% less funds holding in top 10

Funds holding in top 10: 6 → 3 (-3)

53% less capital invested

Capital invested by funds: $863M → $403M (-$460M)

Holders
70
Holders Change
+4
Holders Change %
+6.06%
% of All Funds
1.41%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
16
Increased
16
Reduced
20
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
BlackRock
New York
+$1.83M
2
Northern Trust
Northern Trust
Illinois
+$1.77M
3
GPCM
Granite Point Capital Management
Massachusetts
+$1.72M
4
Millennium Management
Millennium Management
New York
+$982K
5
State Street
State Street
Massachusetts
+$538K

Top Sellers

1
Alkeon Capital Management
Alkeon Capital Management
New York
-$13.8M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$4.92M
3
AG
Artal Group
Luxembourg
-$3.76M
4
AI
Atom Investors
Texas
-$2.13M
5
CCM
CAAS Capital Management
New York
-$1.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$91.3M – – –
FM
2
Frazier Management
Washington
$65.7M – – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$62M -$666K -1,935 -0.8%
NLVP
4
New Leaf Venture Partners
New York
$32.7M – – –
VC
5
Vivo Capital
California
$28.7M -$656K -1,906 -2%
BC
6
Boxer Capital
California
$25.3M – – –
BlackRock
7
BlackRock
New York
$19.8M +$1.83M +5,322 +8%
HCM
8
Highline Capital Management
New York
$7.87M -$817K -2,374 -7%
Vanguard Group
9
Vanguard Group
Pennsylvania
$6.79M -$152K -442 -2%
Morgan Stanley
10
Morgan Stanley
New York
$5.37M +$300K +871 +4%
LGM
11
Logos Global Management
California
$4.52M – – –
EA
12
Emerald Advisers
Pennsylvania
$4.48M -$191K -556 -3%
EMFAT
13
Emerald Mutual Fund Advisers Trust
Pennsylvania
$4.29M – – –
RCM
14
RA Capital Management
Massachusetts
$4.23M – – –
Alyeska Investment Group
15
Alyeska Investment Group
Illinois
$3.81M – – –
SFM
16
Sphera Funds Management
Israel
$3.49M -$1.35M -3,920 -23%
BBA
17
Baker Bros. Advisors
New York
$3.42M -$240K -697 -5%
HA
18
HHLR Advisors
Cayman Islands
$3.29M – – –
State Street
19
State Street
Massachusetts
$3.02M +$538K +1,563 +16%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$2.8M +$39.2K +114 +1%
RSCM
21
Rock Springs Capital Management
Maryland
$2.7M +$44.7K +130 +1%
Northern Trust
22
Northern Trust
Illinois
$2.24M +$1.77M +5,153 +152%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$2.14M -$158K -460 -5%
WMSA
24
Weiss Multi-Strategy Advisers
New York
$2M +$133K +386 +5%
Charles Schwab
25
Charles Schwab
California
$1.35M +$315K +915 +22%
1
2 3 4

PASG Hedge Fund Activity: Q3 2020 in Review

70 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Passage Bio (PASG) for Q3 2020, worth a combined $403M — down 53% from $863M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new PASG positions and 12 closed out — a net gain of 4 holders — while 16 added to existing stakes and 20 trimmed.

The largest buyer was BlackRock, adding an estimated $1.83M. The largest seller was Alkeon Capital Management, exiting entirely with an estimated $13.8M sold.

  • 70 institutional investors held Passage Bio (PASG) as of Q3 2020, up from 66 in Q2 2020.
  • Funds reported $403M of Passage Bio stock for Q3 2020, down 53% quarter-over-quarter.
  • 16 funds opened new Passage Bio positions in Q3 2020 and 12 closed out, a net change of +4 holders.
  • The largest Passage Bio buyer in Q3 2020 was BlackRock, an estimated $1.83M added.
  • The largest Passage Bio seller in Q3 2020 was Alkeon Capital Management, an estimated $13.8M sold.

Based on aggregated 13F filings for Q3 2020.